Grifols is a leading global healthcare company. Our trusted and innovative plasma-derived medicines, other biopharmaceuticals and solutions in transfusion medicine enable millions of patients around the world to lead more productive lives.
Since our founding in 1909, our ever-growing mastery of plasma, diagnostics and life sciences, backed by our ethical leadership and industry-leading quality and safety standards, have contributed to a healthier and more sustainable society.
CHRONOS-PD: Plasma Science in Parkinson’s Research
Seeking early biological signs of disease.
Latest news
Grifols discloses transfers of value made to European healthcare professionals and healthcare organizations in 2024
Grifols’ positive fibrinogen phase 3 trial results published in The Lancet’s eClinicalMedicine
Grifols successfully completes Biotest delisting
Commitment to people and the planet
Aligned with the United Nations plan to achieve the Sustainable Development Goals defined in its 2030 Agenda, we work every day to do more and do better to contribute to the health and quality of life of people around the world.
The patients we serve are able to lead better lives. Patients inspire the work we do every day.
Committed to women's sports
Promoting a more inclusive, fair and equal society for everyone is essential to our mission of contributing to a better world. Sports serve as a powerful tool to achieve these goals.
Scientific innovation at work
Our deep and expanding knowledge of plasma and the life sciences is helping us better understand human health and research potential treatments to improve it.
Get to know us
Our history
We trace our roots back to 1909 when Dr. Josep Antoni Grifols i Roig founded a clinical analysis laboratory in Barcelona, the precursor to Laboratorios Grifols.
Company
Grifols' mission, to improve people's health and well-being, has patients, donors and society at the heart of everything we do.
Careers
Would you like to make a positive impact on the lives of others? Join our team!
Lifegiving plasma
Our innovative medicines made from human plasma enable millions of patients with chronic and rare diseases to lead more fulfilling lives.